-
Jan 7, 2025 | 
jamanetwork.com | Roy H. Perlis |Ata A Uslu |Jonathan Schulman |Mauricio Santillana
Question Is social media use by adults associated with irritability, or being prone to anger? Findings In this survey study of 42 597 US adults, high levels of social media use, in particular frequent posting, were associated with greater irritability in cross-sectional analysis. Meaning The association between social media and irritability merits further attention, given the known associations between irritability and adverse outcomes.
-
Oct 18, 2024 | 
jamanetwork.com | Roy H. Perlis
This conversation is part of a series of interviews in which JAMA Network editors and expert guests explore issues surrounding the rapidly evolving intersection of artificial intelligence (AI) and medicine.
Throughout her career, Tanzeem Choudhury, PhD, has worked at the intersection of wearable computing, AI, and health care. Over time, she came to see that tracking activity-related behaviors with wearable devices had the potential to support well-being before people became sick.
-
Oct 8, 2024 | 
jamanetwork.com | Roy H. Perlis
This conversation is part of a series of interviews in which JAMA Network editors and expert guests explore issues surrounding the rapidly evolving intersection of artificial intelligence (AI) and medicine.
Stephan Fihn, MD, MPH, a primary care physician and health services researcher, spent 36 years in leadership roles at the US Department of Veterans Affairs (VA), an early adopter of AI. Much of his time at the VA was devoted to incorporating informatics into improving quality of care.
-
Oct 8, 2024 | 
jamanetwork.com | Roy H. Perlis |Kirsten Bibbins-Domingo
The application of artificial intelligence (AI) to address challenges in health care is almost universally described as transformative. Acknowledging the rapid pace at which tools incorporating AI have advanced toward clinical practice, prior JAMA editorials1,2 noted the importance of ensuring the rigorous evaluation of approaches using AI at every stage of development.
-
Oct 1, 2024 | 
nature.com | Abhishek Jaywant |Roy H. Perlis
AbstractPost-COVID-19 cognitive deficits are common, persistent, and disabling. Evidence on effective treatments is limited. The goal of this study was to investigate the efficacy of a digital intervention to reduce cognitive and functional deficits in adults with persistent post-COVID-19 cognitive dysfunction. We used the remotely-delivered intervention in a randomized clinical trial conducted from July 13, 2021 to April 26, 2023.
-
Sep 24, 2024 | 
medrxiv.org | Roy H. Perlis
Dr. Perlis has received fees for scientific advising from Belle AI, Genomind, Circular Genomics, Mila Health, Vault Health, and Alkermes, outside of the present work. He holds equity in Psy Therapeutics and Circular Genomics. He serves as Editor-in-Chief of JAMA Artificial Intelligence and Associate Editor at JAMA Network Open. Dr. Perlis is supported in part by the National Institute of Mental Health (R01MH123804, U01MH136059).
-
Aug 21, 2024 | 
healio.com | Emma Bascom |Roy H. Perlis |Carol L. DiBerardino
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Adults’ trust in physicians and hospitals dropped markedly between April 2020 and January 2024. An expert discussed the reasons behind this, connected health outcomes and how to regain that trust.
-
Jul 31, 2024 | 
jamanetwork.com | Roy H. Perlis |Katherine Ognyanova |New Brunswick |New jersey
Key PointsQuestion How did trust in physicians and hospitals change during the COVID-19 pandemic? Findings In every sociodemographic group in this survey study among 443 455 unique respondents aged 18 years or older residing in the US, trust in physicians and hospitals decreased substantially over the course of the pandemic, from 71.5% in April 2020 to 40.1% in January 2024. Individuals with lower levels of trust were less likely to have been vaccinated or received boosters for COVID-19.
-
Jul 10, 2024 | 
jamanetwork.com | Sarah Rathnam |Thomas McCoy |Finale Doshi-Velez |Roy H. Perlis
Key PointsQuestion
To what extent do differences in clinician setting explain variability in major depression treatments and outcomes? Findings
In this cohort study derived from electronic health record data, antidepressant prescribing patterns and outcomes varied significantly between prescriber groups. Clinician clusters were significantly associated with clinical outcomes.
-
Jul 1, 2024 | 
medrxiv.org | Roy H. Perlis
Dr. Perlis has received consulting fees from Belle AI, Genomind, Circular Genomics, Vault Health, and Alkermes, outside of the present work. He holds equity in Psy Therapeutics, Belle AI, Circular Genomics, and Swan AI Studios. Dr. Perlis is supported in part by the National Institute of Mental Health (R01MH123804, U01MH136059). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
